Skip to main content
. Author manuscript; available in PMC: 2012 Aug 11.
Published in final edited form as: J Med Chem. 2011 Jul 18;54(15):5522–5531. doi: 10.1021/jm2005767

Table 1.

Inhibition of Human α-Thrombin by Sulfated Benzofuran Monomers.a

R R′ log IC50 (M) IC50 (μM) ΔY
5a —OCH2CH3 —CH3 ndb >2500c -
5b —OCH3 —CH3 nd >3000c -
5c —OC(CH3)3 —CH3 nd >3000c -
5d —OCH2 CH2OCH3 —CH3 nd >2000c -
5e —OCH2CH3 —CH2CH3 −1.7±0.2d 20560±8500 0.60
5f —OCH2CH3 —CH(CH3)2 −1.9±0.3 13650±10400 0.75
5g —OCH2CH3 —CH2OCH3 nd >16000c -
5h —OCH2CH3 Morpholine-4-carbonyl nd >25,000c -
5i —OCH2CH3 Benzoyl-p-methoxy −3.3±0.2 520±280 0.54
5j —OCH2CH=CH2 —CH3 nd >3000 -
9a N-morpholino —CH3 nd >2000c -
9b N-piperidino —CH3 nd >2000c -
10e —CH2CH3 —CH3 nd >7000c -
a

Thrombin inhibition was measured in spectrophotometric assay through initial rate of Spectrozyme TH hydrolysis as described in Experimental section.

b

Not determined due to incomplete and/or poor inhibition.

c

Estimates on the basis of the highest concentration used in experiment.

d

standard error shown is ±1 S.E.

e

10 contains a morpholine group at the allylic position (instead of a –CH3 group). See Figure 2 for the full structure.